Research Analysts’ updated eps estimates for Friday, September 15th:

AbbVie (NYSE:ABBV) had its overweight rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $100.00 price target on the stock.

AbbVie (NYSE:ABBV) had its top pick rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $107.00 price target on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its hold rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $2.00 price target on the stock. The analysts wrote, “ARO-AAT and ARO-HBV in 1H18. Arrowhead’s lead preclinical programs are expected to have CTAs filed in 1Q18 and 2Q18, respectively. Gating items for these candidates include GLP toxicity studies (both candidates) and completion of cross reactivity studies for ARO-HBV. We are encouraged by the significant progress made and the established guidance to reach the clinic with two candidates by 1H18.””

Ballard Power Systems (NASDAQ:BLDP) (TSE:BLD) had its buy rating reaffirmed by analysts at HC Wainwright.

Imperial Brands PLC (LON:IMT) had its buy rating reiterated by analysts at Whitman Howard. They currently have a GBX 5,100 ($65.87) target price on the stock.

Inditex SA (BME:ITX) had its neutral rating reiterated by analysts at UBS AG.

Oracle Corporation (NYSE:ORCL) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $58.00 price target on the stock.

Snap (NYSE:SNAP) had its buy rating reiterated by analysts at Cantor Fitzgerald. They currently have a $17.00 price target on the stock. The analysts wrote, “Monetization per minute has significant upside potential… We’re modeling for Snap’s 2017 US ad revenue per DAU (ARPU) to rise 53.4% y/y to $9.56 (vs. FB’s (OW) $103.31), and for its 2017 US ad rev per min (x 1,000) to also rise by 53.4% y/y to $0.87 (vs. FB’s $5.66). On both counts, we believe Snap’s monetization has room to go substantially higher as bid density improves on the self-serve platform and as mobile video/ads in the Discover tab ramp up.””

Salzgitter AG (ETR:SZG) had its neutral rating reissued by analysts at Jefferies Group LLC.

ThyssenKrupp AG (FRA:TKA) had its buy rating reiterated by analysts at Jefferies Group LLC.

Zalando Se (NASDAQ:ZLDSF) had its sell rating reiterated by analysts at UBS AG.

Receive News & Ratings for AbbVie Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbbVie Inc and related companies with MarketBeat.com's FREE daily email newsletter.